Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea
· Delayed Price · Currency is KRW 9,350.00
+70.00 (0.75%)
At close: Apr 28, 2026
Pharos iBio Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Operating Revenue | - | - | - | 300 | 57 | Upgrade
|
| Other Revenue | - | - | - | - | -0 | Upgrade
|
| Revenue | - | - | - | 300 | 57 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | 426.32% | -69.63% | Upgrade
|
| Cost of Revenue | 20.32 | 25.93 | 11.02 | 192.49 | 52.09 | Upgrade
|
| Gross Profit | -20.32 | -25.93 | -11.02 | 107.52 | 4.91 | Upgrade
|
| Selling, General & Admin | 2,913 | 3,276 | 3,226 | 2,988 | 2,459 | Upgrade
|
| Research & Development | 7,677 | 8,458 | 6,138 | 7,085 | 5,544 | Upgrade
|
| Amortization of Goodwill & Intangibles | 73.12 | 71.31 | 69.18 | 67.33 | 111.15 | Upgrade
|
| Other Operating Expenses | 59.25 | 38.31 | 56.29 | 75.93 | 57.34 | Upgrade
|
| Operating Expenses | 11,487 | 12,575 | 10,106 | 10,727 | 8,411 | Upgrade
|
| Operating Income | -11,507 | -12,601 | -10,117 | -10,619 | -8,406 | Upgrade
|
| Interest Expense | -63.57 | -6.01 | -11.24 | -3,222 | -6,513 | Upgrade
|
| Interest & Investment Income | 341.88 | 809.98 | 690.24 | 320.48 | 116.43 | Upgrade
|
| Currency Exchange Gain (Loss) | -110.47 | 717.62 | 28.37 | 346.05 | 205.32 | Upgrade
|
| Other Non Operating Income (Expenses) | 582.62 | 556.6 | 592.65 | -3,911 | -16,877 | Upgrade
|
| EBT Excluding Unusual Items | -10,757 | -10,523 | -8,817 | -17,086 | -31,474 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.01 | -37.27 | -41.7 | 24.43 | 3.2 | Upgrade
|
| Pretax Income | -10,757 | -10,560 | -8,858 | -17,062 | -31,471 | Upgrade
|
| Net Income | -10,757 | -10,560 | -8,858 | -17,062 | -31,471 | Upgrade
|
| Net Income to Common | -10,757 | -10,560 | -8,858 | -17,062 | -31,471 | Upgrade
|
| Shares Outstanding (Basic) | 13 | 13 | 12 | 9 | 6 | Upgrade
|
| Shares Outstanding (Diluted) | 13 | 13 | 12 | 9 | 6 | Upgrade
|
| Shares Change (YoY) | 0.14% | 6.81% | 36.26% | 53.03% | 2.65% | Upgrade
|
| EPS (Basic) | -831.00 | -817.00 | -732.03 | -1921.10 | -5422.59 | Upgrade
|
| EPS (Diluted) | -831.00 | -817.00 | -732.03 | -1921.10 | -5422.59 | Upgrade
|
| Free Cash Flow | -8,362 | -10,004 | -8,253 | -8,512 | -8,489 | Upgrade
|
| Free Cash Flow Per Share | -646.04 | -773.98 | -681.98 | -958.46 | -1462.70 | Upgrade
|
| Gross Margin | - | - | - | 35.84% | 8.61% | Upgrade
|
| Operating Margin | - | - | - | -3539.83% | -14747.27% | Upgrade
|
| Profit Margin | - | - | - | -5687.23% | -55211.96% | Upgrade
|
| Free Cash Flow Margin | - | - | - | -2837.42% | -14892.94% | Upgrade
|
| EBITDA | -10,670 | -11,798 | -9,432 | -10,041 | -8,056 | Upgrade
|
| D&A For EBITDA | 837.49 | 802.91 | 684.91 | 578.1 | 350.09 | Upgrade
|
| EBIT | -11,507 | -12,601 | -10,117 | -10,619 | -8,406 | Upgrade
|
| Advertising Expenses | 109.8 | 47.12 | - | - | 0.2 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.